Literature DB >> 27280246

Application of Gold Nanorods for Photothermal Therapy in Ex Vivo Human Oesophagogastric Adenocarcinoma.

Mohan Singh, David C C Harris-Birtill, Yu Zhou, Maria E Gallina, Anthony E G Cass, George B Hanna, Daniel S Elson.   

Abstract

Gold nanoparticles are chemically fabricated and tuned to strongly absorb near infrared (NIR) light, enabling deep optical penetration and therapy within human tissues, where sufficient heating induces tumour necrosis. In our studies we aim to establish the optimal gold nanorod (GNR) concentration and laser power for inducing hyperthermic effects in tissues and test this photothermal effect on ex vivo human oesophagogastric adenocarcinoma. The ideal GNR concentration and NIR laser power that would elicit sufficient hyperthermia for tumour necrosis was pre-determined on porcine oesophageal tissues. Human ex vivo oesophageal and gastric adenocarcinoma tissues were incubated with GNR solutions and a GNR-free control solution with corresponding healthy tissues for comparison, then irradiated with NIR light for 10 minutes. Temperature rise was found to vary linearly with both the concentration of GNRs and the laser power. Human ex vivo oesophageal and gastric tissues consistently demonstrated a significant temperature rise when incubated in an optimally concentrated GNR solution (3 x 10(10) GNRs/ml) prior to NIR irradiation delivered at an optimal power (2 W/cm2). A mean temperature rise of 27 degrees C was observed in tissues incubated with GNRs, whereas only a modest 2 degrees C rise in tissues not exposed to any GNRs. This study evaluates the photothermal effects of GNRs on oesophagogastric tissue examines their application in the minimally invasive therapeutics of oesophageal and gastric adenocarcinomas. This could potentially be an effective method of clinically inducing irreversible oesophagogastric tumour photodestruction, with minimal collateral damage expected in (healthy) tissues free from GNRs.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27280246     DOI: 10.1166/jbn.2016.2196

Source DB:  PubMed          Journal:  J Biomed Nanotechnol        ISSN: 1550-7033            Impact factor:   4.099


  7 in total

1.  Photosensitizer Micelles Together with IDO Inhibitor Enhance Cancer Photothermal Therapy and Immunotherapy.

Authors:  Jinrong Peng; Yao Xiao; Wenting Li; Qian Yang; Liwei Tan; Yanpeng Jia; Ying Qu; Zhiyong Qian
Journal:  Adv Sci (Weinh)       Date:  2018-02-26       Impact factor: 16.806

Review 2.  Recent advances in functional nanostructures as cancer photothermal therapy.

Authors:  Essraa A Hussein; Moustafa M Zagho; Gheyath K Nasrallah; Ahmed A Elzatahry
Journal:  Int J Nanomedicine       Date:  2018-05-17

Review 3.  Encapsulation of Gold Nanorods with Porphyrins for the Potential Treatment of Cancer and Bacterial Diseases: A Critical Review.

Authors:  Nthabeleng Hlapisi; Tshwafo E Motaung; Linda Z Linganiso; Oluwatobi S Oluwafemi; Sandile P Songca
Journal:  Bioinorg Chem Appl       Date:  2019-04-30       Impact factor: 7.778

Review 4.  Improvement of Gold Nanorods in Photothermal Therapy: Recent Progress and Perspective.

Authors:  Shengnan Liao; Wang Yue; Shuning Cai; Quan Tang; Weitong Lu; Lingxiao Huang; Tingting Qi; Jinfeng Liao
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

5.  In Vitro Evaluation of DSPE-PEG (5000) Amine SWCNT Toxicity and Efficacy as a Novel Nanovector Candidate in Photothermal Therapy by Response Surface Methodology (RSM).

Authors:  Naghmeh Hadidi; Niloufar Shahbahrami Moghadam; Gholamreza Pazuki; Parviz Parvin; Fatemeh Shahi
Journal:  Cells       Date:  2021-10-25       Impact factor: 6.600

Review 6.  Nanotechnology-based strategies for gastric cancer imaging and treatment.

Authors:  Xianghui Li; Shichao Ai; Xiaofeng Lu; Song Liu; Wenxian Guan
Journal:  RSC Adv       Date:  2021-11-02       Impact factor: 4.036

7.  Near-infrared photothermal therapy using anti-EGFR-gold nanorod conjugates for triple negative breast cancer.

Authors:  Meihua Zhang; Hoe Suk Kim; Tiefeng Jin; Jisu Woo; Yin Ji Piao; Woo Kyung Moon
Journal:  Oncotarget       Date:  2017-09-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.